Company: DNLI
Filing Date: 2025-12-04
Form Type: 8-K
Source: 0001714899-25-000209
Chunk: 0

Company: Denali Therapeutics Inc.
Filing Date: 2025-12-04
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On December 4, 2025, Denali Therapeutics Inc. (“ Denali” or the “ Company”) hosted its 2025 Investor Day, during which members of the Company’s executive management team provided updates on Denali’s development programs and upcoming milestones. A copy of the presentation made available in connection with the 2025 Investor Day is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 8.01 Other Events